Constructive Deep Neural Network for Breast Cancer Diagnosis

Trends in using deep learning algorithms in biomedical prediction systems

In the domain of using DL-based methods in medical and healthcare prediction systems, the utilization of state-of-the-art deep learning (DL) methodologies assumes paramount significance. DL has attained remarkable achievements across diverse domains, rendering its efficacy particularly noteworthy in this context. The integration of DL with health and medical prediction systems enables real-time analysis of vast and intricate datasets, yielding insights that significantly enhance healthcare outcomes and operational efficiency in the industry. This comprehensive literature review systematically investigates the latest DL solutions for the challenges encountered in medical healthcare, with a specific emphasis on DL applications in the medical domain. By categorizing cutting-edge DL approaches into distinct categories, including convolutional neural networks (CNNs), recurrent neural networks (RNNs), generative adversarial networks (GANs), long short-term memory (LSTM) models, support vector machine (SVM), and hybrid models, this study delves into their underlying principles, merits, limitations, methodologies, simulation environments, and datasets. Notably, the majority of the scrutinized articles were published in 2022, underscoring the contemporaneous nature of the research. Moreover, this review accentuates the forefront advancements in DL techniques and their practical applications within the realm of medical prediction systems, while simultaneously addressing the challenges that hinder the widespread implementation of DL in image segmentation within the medical healthcare domains. These discerned insights serve as compelling impetuses for future studies aimed at the progressive advancement of using DL-based methods in medical and health prediction systems. The evaluation metrics employed across the reviewed articles encompass a broad spectrum of features, encompassing accuracy, precision, specificity, F-score, adoptability, adaptability, and scalability.

Bio-Imaging-Based Machine Learning Algorithm for Breast Cancer Detection

Breast cancer is one of the most widespread diseases in women worldwide. It leads to the second-largest mortality rate in women, especially in European countries. It occurs when malignant lumps that are cancerous start to grow in the breast cells. Accurate and early diagnosis can help in increasing survival rates against this disease. A computer-aided detection (CAD) system is necessary for radiologists to differentiate between normal and abnormal cell growth. This research consists of two parts; the first part involves a brief overview of the different image modalities, using a wide range of research databases to source information such as ultrasound, histography, and mammography to access various publications. The second part evaluates different machine learning techniques used to estimate breast cancer recurrence rates. The first step is to perform preprocessing, including eliminating missing values, data noise, and transformation. The dataset is divided as follows: 60% of the dataset is used for training, and the rest, 40%, is used for testing. We focus on minimizing type one false-positive rate (FPR) and type two false-negative rate (FNR) errors to improve accuracy and sensitivity. Our proposed model uses machine learning techniques such as support vector machine (SVM), logistic regression (LR), and K-nearest neighbor (KNN) to achieve better accuracy in breast cancer classification. Furthermore, we attain the highest accuracy of 97.7% with 0.01 FPR, 0.03 FNR, and an area under the ROC curve (AUC) score of 0.99. The results show that our proposed model successfully classifies breast tumors while overcoming previous research limitations. Finally, we summarize the paper with the future trends and challenges of the classification and segmentation in breast cancer detection.

A Long Short-Term Memory Biomarker-Based Prediction Framework for Alzheimer's Disease

The early prediction of Alzheimer's disease (AD) can be vital for the endurance of patients and establishes as an accommodating and facilitative factor for specialists. The proposed work presents a robotized predictive structure, dependent on machine learning (ML) methods for the forecast of AD. Neuropsychological measures (NM) and magnetic resonance imaging (MRI) biomarkers are deduced and passed on to a recurrent neural network (RNN). In the RNN, we have used long short-term memory (LSTM), and the proposed model will predict the biomarkers (feature vectors) of patients after 6, 12, 21 18, 24, and 36 months. These predicted biomarkers will go through fully connected neural network layers. The NN layers will then predict whether these RNN-predicted biomarkers belong to an AD patient or a patient with a mild cognitive impairment (MCI). The developed methodology has been tried on an openly available informational dataset (ADNI) and accomplished an accuracy of 88.24%, which is superior to the next-best available algorithms.

Preoperative AI-Driven Fluorescence Diagnosis of Non-Melanoma Skin Cancer

The diagnosis and treatment of non-melanoma skin cancer remain urgent problems. Histological examination of biopsy material—the gold standard of diagnosis—is an invasive procedure that requires a certain amount of time to perform. The ability to detect abnormal cells using fluorescence spectroscopy (FS) has been shown in many studies. This technique is rapidly expanding due to its safety, relative cost-effectiveness, and efficiency. However, skin lesion FS-based diagnosis is challenging due to a number of single overlapping spectra emitted by fluorescent molecules, making it difficult to distinguish changes in the overall spectrum and the molecular basis for it. We applied deep learning (DL) algorithms to quantitatively assess the ability of FS to differentiate between pathologies and normal skin. A total of 137 patients with various forms of primary and recurrent basal cell carcinoma (BCC) were observed by a multispectral laser-based device with a built-in neural network (NN) “DSL-1”. We measured the fluorescence spectra of suspected non-melanoma skin cancers and compared them with “normal” skin spectra. These spectra were input into DL algorithms to determine whether the skin is normal, pigmented normal, benign, or BCC. The preoperative differential AI-driven fluorescence diagnosis method correctly predicted the BCC lesions. We obtained an average sensitivity of 62% and average specificity of 83% in our experiments. Thus, the presented “DSL-1” diagnostic device can be a viable tool for the real-time diagnosis and guidance of non-melanoma skin cancer resection.

Breast Cancer Detection Using Mammogram Images with Improved Multi-Fractal Dimension Approach and Feature Fusion

Breast cancer detection using mammogram images at an early stage is an important step in disease diagnostics. We propose a new method for the classification of benign or malignant breast cancer from mammogram images. Hybrid thresholding and the machine learning method are used to derive the region of interest (ROI). The derived ROI is then separated into five different blocks. The wavelet transform is applied to suppress noise from each produced block based on BayesShrink soft thresholding by capturing high and low frequencies within different sub-bands. An improved fractal dimension (FD) approach, called multi-FD (M-FD), is proposed to extract multiple features from each denoised block. The number of features extracted is then reduced by a genetic algorithm. Five classifiers are trained and used with the artificial neural network (ANN) to classify the extracted features from each block. Lastly, the fusion process is performed on the results of five blocks to obtain the final decision. The proposed approach is tested and evaluated on four benchmark mammogram image datasets (MIAS, DDSM, INbreast, and BCDR). We present the results of single- and double-dataset evaluations. Only one dataset is used for training and testing in the single-dataset evaluation, whereas two datasets (one for training, and one for testing) are used in the double-dataset evaluation. The experiment results show that the proposed method yields better results on the INbreast dataset in the single-dataset evaluation, whilst better results are obtained on the remaining datasets in the double-dataset evaluation. The proposed approach outperforms other state-of-the-art models on the Mini-MIAS dataset.

Radiomics Nomogram Based on Radiomics Score from Multiregional Diffusion-Weighted MRI and Clinical Factors for Evaluating HER-2 2+ Status of Breast Cancer

This study aimed to establish and validate a radiomics nomogram using the radiomics score (rad-score) based on multiregional diffusion-weighted imaging (DWI) and apparent diffusion coefficient (ADC) features combined with clinical factors for evaluating HER-2 2+ status of breast cancer. A total of 223 patients were retrospectively included. Radiomic features were extracted from multiregional DWI and ADC images. Based on the intratumoral, peritumoral, and combined regions, three rad-scores were calculated using the logistic regression model. Independent parameters were selected among clinical factors and combined rad-score (com-rad-score) using multivariate logistic analysis and used to construct a radiomics nomogram. The performance of the nomogram was evaluated using calibration, discrimination, and clinical usefulness. The areas under the receiver operator characteristic curve (AUCs) of intratumoral and peritumoral rad-scores were 0.824/0.763 and 0.794/0.731 in the training and validation cohorts, respectively. Com-rad-score achieved the highest AUC (0.860/0.790) among three rad-scores. ER status and com-rad-score were selected to establish the nomogram, which yielded good discrimination (AUC: 0.883/0.848) and calibration. Decision curve analysis demonstrated the clinical value of the nomogram in the validation cohort. In conclusion, radiomics nomogram, including clinical factors and com-rad-score, showed favorable performance for evaluating HER-2 2+ status in breast cancer.

Back propagation neural network model for medical expenses in patients with breast cancer

OBJECTIVE

Breast cancer seriously endangers women's life and health, and brings huge economic burden to the family and society. The aim of this study was to analyze the medical expenses and influencing factors of breast cancer patients, and provide theoretical basis for reasonable control of medical expenses of breast cancer patients.

METHODS

The medical expenses and related information of all female breast cancer patients diagnosed in our hospitals from 2017 to 2019 were collected. Through SSPS Clementine 12.0 software, the back propagation (BP) neural network model and multiple linear regression model were constructed respectively, and the influencing factors of medical expenses of breast cancer patients in the two models were compared.

RESULTS

In the study of medical expenses of breast cancer patients, the prediction error of BP neural network model is less than that of multiple linear regression model. At the same time, the results of the two models showed that the length of stay and region were the top two factors affecting the medical expenses of breast cancer patients.

CONCLUSION

Compared with multiple linear regression model, BP neural network model is more suitable for the analysis of medical expenses in patients with breast cancer.

Conventional Machine Learning versus Deep Learning for Magnification Dependent Histopathological Breast Cancer Image Classification: A Comparative Study with Visual Explanation

Breast cancer is a serious threat to women. Many machine learning-based computer-aided diagnosis (CAD) methods have been proposed for the early diagnosis of breast cancer based on histopathological images. Even though many such classification methods achieved high accuracy, many of them lack the explanation of the classification process. In this paper, we compare the performance of conventional machine learning (CML) against deep learning (DL)-based methods. We also provide a visual interpretation for the task of classifying breast cancer in histopathological images. For CML-based methods, we extract a set of handcrafted features using three feature extractors and fuse them to get image representation that would act as an input to train five classical classifiers. For DL-based methods, we adopt the transfer learning approach to the well-known VGG-19 deep learning architecture, where its pre-trained version on the large scale ImageNet, is block-wise fine-tuned on histopathological images. The evaluation of the proposed methods is carried out on the publicly available BreaKHis dataset for the magnification dependent classification of benign and malignant breast cancer and their eight sub-classes, and a further validation on KIMIA Path960, a magnification-free histopathological dataset with 20 image classes, is also performed. After providing the classification results of CML and DL methods, and to better explain the difference in the classification performance, we visualize the learned features. For the DL-based method, we intuitively visualize the areas of interest of the best fine-tuned deep neural networks using attention maps to explain the decision-making process and improve the clinical interpretability of the proposed models. The visual explanation can inherently improve the pathologist’s trust in automated DL methods as a credible and trustworthy support tool for breast cancer diagnosis. The achieved results show that DL methods outperform CML approaches where we reached an accuracy between 94.05% and 98.13% for the binary classification and between 76.77% and 88.95% for the eight-class classification, while for DL approaches, the accuracies range from 85.65% to 89.32% for the binary classification and from 63.55% to 69.69% for the eight-class classification.

Cloud Computing-Based Framework for Breast Cancer Diagnosis Using Extreme Learning Machine

Globally, breast cancer is one of the most significant causes of death among women. Early detection accompanied by prompt treatment can reduce the risk of death due to breast cancer. Currently, machine learning in cloud computing plays a pivotal role in disease diagnosis, but predominantly among the people living in remote areas where medical facilities are scarce. Diagnosis systems based on machine learning act as secondary readers and assist radiologists in the proper diagnosis of diseases, whereas cloud-based systems can support telehealth services and remote diagnostics. Techniques based on artificial neural networks (ANN) have attracted many researchers to explore their capability for disease diagnosis. Extreme learning machine (ELM) is one of the variants of ANN that has a huge potential for solving various classification problems. The framework proposed in this paper amalgamates three research domains: Firstly, ELM is applied for the diagnosis of breast cancer. Secondly, to eliminate insignificant features, the gain ratio feature selection method is employed. Lastly, a cloud computing-based system for remote diagnosis of breast cancer using ELM is proposed. The performance of the cloud-based ELM is compared with some state-of-the-art technologies for disease diagnosis. The results achieved on the Wisconsin Diagnostic Breast Cancer (WBCD) dataset indicate that the cloud-based ELM technique outperforms other results. The best performance results of ELM were found for both the standalone and cloud environments, which were compared. The important findings of the experimental results indicate that the accuracy achieved is 0.9868, the recall is 0.9130, the precision is 0.9054, and the F1-score is 0.8129.

The Utility of Deep Learning in Breast Ultrasonic Imaging: A Review

Breast cancer is the most frequently diagnosed cancer in women; it poses a serious threat to women's health. Thus, early detection and proper treatment can improve patient prognosis. Breast ultrasound is one of the most commonly used modalities for diagnosing and detecting breast cancer in clinical practice. Deep learning technology has made significant progress in data extraction and analysis for medical images in recent years. Therefore, the use of deep learning for breast ultrasonic imaging in clinical practice is extremely important, as it saves time, reduces radiologist fatigue, and compensates for a lack of experience and skills in some cases. This review article discusses the basic technical knowledge and algorithms of deep learning for breast ultrasound and the application of deep learning technology in image classification, object detection, segmentation, and image synthesis. Finally, we discuss the current issues and future perspectives of deep learning technology in breast ultrasound.

Prediction of Oncotype DX recurrence score using deep multi-layer perceptrons in estrogen receptor-positive, HER2-negative breast cancer

Oncotype DX (ODX) is a multi-gene expression signature designed for estrogen receptor (ER)-positive and human epidermal growth factor receptor 2 (HER2)-negative breast cancer patients to predict the recurrence score (RS) and chemotherapy (CT) benefit. The aim of our study is to develop a prediction tool for the three RS's categories based on deep multi-layer perceptrons (DMLP) and using only the morphoimmunohistological variables. We performed a retrospective cohort of 320 patients who underwent ODX testing from three French hospitals. Clinico-pathological characteristics were recorded. We built a supervised machine learning classification model using Matlab software with 152 cases for the training and 168 cases for the testing. Three classifiers were used to learn the three risk categories of the ODX, namely the low, intermediate, and high risk. Experimental results provide the area under the curve (AUC), respectively, for the three risk categories: 0.63 [95% confidence interval: (0.5446, 0.7154), p < 0.001], 0.59 [95% confidence interval: (0.5031, 0.6769), p < 0.001], 0.75 [95% confidence interval: (0.6184, 0.8816), p < 0.001]. Concordance rate between actual RS and predicted RS ranged from 53 to 56% for each class between DMLP and ODX. The concordance rate of low and intermediate combined risk group was 85%.We developed a predictive machine learning model that could help to define patient's RS. Moreover, we integrated histopathological data and DMLP results to select tumor for ODX testing. Thus, this process allows more relevant use of histopathological data, and optimizes and enhances this information.